Sheep immune response against a novel recombinant enterotoxemia and infectious necrotic hepatitis vaccine in Türkiye by Dilek Nur Ekinoğlu, Venhar Çelik, Esra Gül, Hakan Kalender, Hasan Öngör, Burhan Çetinkaya

“…On the other hand, the average values in sheep immunised with commercial vaccine were detected as 8.00 ± 2.14 IU/mL, 4.25 ± 1.67 IU/m L and 6.50 ± 0.93 IU/mL for C. perfringens beta, C. perfringens epsilon and C. novyi alpha, respectively. …”
Get full text

Kinetic of the Maternally‐Derived Anti‐Parvovirus IgG During the Neonatal Period: A Quantitative Assessment by Yalda Tamaddon, Mehran Bakhshesh, Farnoush Arfaee, Mohammad Hossein Fallah Mehrabadi, Nader Azadi

“…Objectives Quantitative evaluation of the anti‐parvovirus IgG transferred to newborn puppies from immunised bitches during the neonatal period, as the influence of individual variations on the kinetics of the specific IgG was also estimated. …”
Get full text

"I would have to sell things in order to get the money": A qualitative exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta region, Ghana. by Sharon Darkwa, Gilles de Wildt, Maxwell Dalaba, Edem Vidzro, Evelyn Korkor Ansah

“…<h4>Conclusions</h4>Participants expressed a willingness to pay due to an appreciation of vaccines, shaped by personal experiences with immunisations and disease. Participants' average income was lower than the national average, potentially affecting the perceived affordability of RTS,S/AS01. …”
Get full text

Population birth outcomes in 2020 and experiences of expectant mothers during the COVID-19 pandemic: A 'born in Wales' mixed methods study using routine data. by Hope Jones, Mike Seaborne, Laura Cowley, David Odd, Shantini Paranjothy, Ashley Akbari, Sinead Brophy

“…Fewer babies were born in 2020 (N = 29,031) compared to 2016-2019 (average N = 32,582). All babies received their immunisations in 2020, but there were minor delays in the timings of immunisations. …”
Get full text

Economic impact of RSV infections in young children attending primary care: a prospective cohort study in five European countries, 2021 to 2023 by Jojanneke van Summeren

“…This study provides essential data to inform cost-effectiveness analyses on novel RSV immunisations.…”
Get full text

Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo. by Thea Hogan, Ulrich Kadolsky, Sim Tung, Benedict Seddon, Andrew Yates

“…Our analyses demonstrate how population-averaged parameters in models of immune responses can be dissected to account for both spatial and cellular heterogeneity.…”
Get full text